Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk.

Rossner P Jr, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):639-44.

2.

Urinary biomarkers of oxidative status.

Il'yasova D, Scarbrough P, Spasojevic I.

Clin Chim Acta. 2012 Oct 9;413(19-20):1446-53. doi: 10.1016/j.cca.2012.06.012. Epub 2012 Jun 7. Review.

3.

F₂-isoprostane formation, measurement and interpretation: the role of exercise.

Nikolaidis MG, Kyparos A, Vrabas IS.

Prog Lipid Res. 2011 Jan;50(1):89-103. doi: 10.1016/j.plipres.2010.10.002. Epub 2010 Oct 15. Review.

PMID:
20951733
4.

F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome.

Durand T, De Felice C, Signorini C, Oger C, Bultel-Poncé V, Guy A, Galano JM, Leoncini S, Ciccoli L, Pecorelli A, Valacchi G, Hayek J.

Biochimie. 2013 Jan;95(1):86-90. doi: 10.1016/j.biochi.2012.09.017. Epub 2012 Sep 23. Review.

PMID:
23009927
5.

Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective.

Lowe FJ, Luettich K, Gregg EO.

Biomarkers. 2013 May;18(3):183-95. doi: 10.3109/1354750X.2013.777116. Epub 2013 Mar 27. Review.

Supplemental Content

Support Center